Literature DB >> 26686878

Partially nested designs in psychotherapy trials: A review of modeling developments.

Sonya K Sterba1.   

Abstract

OBJECTIVE: Individually-randomized psychotherapy trials are often partially nested. For instance, individuals assigned to a treatment arm may be clustered into therapy groups for purposes of treatment administration, whereas individuals assigned to a wait-list control are unclustered. The past several years have seen rapid expansion and investigation of methods for analyzing partially nested data. Yet partial nesting often remains ignored in psychotherapy trials.
METHODS: This review integrates and disseminates developments in the analysis of partially nested data that are particularly relevant for psychotherapy researchers.
RESULTS: First, we differentiate among alternative partially nested designs. Then, we present adaptations of multilevel model specifications that accommodate each design. Next, we address how moderation by treatment as well as mediation of the treatment effect can be investigated in partially nested designs. Model fitting results, annotated software syntax, and illustrative data sets are provided and key methodological issues are discussed.
CONCLUSIONS: We emphasize that cluster-level variability in the treatment arm need not be considered a nuisance; it can be modeled to yield insights about the treatment process.

Keywords:  group therapy; individually-randomized psychotherapy trials; multilevel modeling; partial clustering; partial nesting

Mesh:

Year:  2015        PMID: 26686878     DOI: 10.1080/10503307.2015.1114688

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  8 in total

1.  Biases in the production and reception of collective knowledge: the case of hindsight bias in Wikipedia.

Authors:  Aileen Oeberst; Ina von der Beck; Mitja D Back; Ulrike Cress; Steffen Nestler
Journal:  Psychol Res       Date:  2017-04-17

2.  Using n-Level Structural Equation Models for Causal Modeling in Fully Nested, Partially Nested, and Cross-Classified Randomized Controlled Trials.

Authors:  Yaacov Petscher; Christopher Schatschneider
Journal:  Educ Psychol Meas       Date:  2019-04-09       Impact factor: 2.821

3.  Anxiety and Depression in Children of Depressed Parents: Dynamics of Change in a Preventive Intervention.

Authors:  Alexandra H Bettis; Rex Forehand; Sonya K Sterba; Kristopher J Preacher; Bruce E Compas
Journal:  J Clin Child Adolesc Psychol       Date:  2016-10-21

4.  Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.

Authors:  Guangyu Tong; Karen H Seal; William C Becker; Fan Li; James D Dziura; Peter N Peduzzi; Denise A Esserman
Journal:  Clin Trials       Date:  2021-10-24       Impact factor: 2.486

5.  Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.

Authors:  Mirjam Moerbeek
Journal:  Clin Trials       Date:  2018-01-10       Impact factor: 2.486

6.  Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.

Authors:  Jane Candlish; M Dawn Teare; Munyaradzi Dimairo; Laura Flight; Laura Mandefield; Stephen J Walters
Journal:  BMC Med Res Methodol       Date:  2018-10-11       Impact factor: 4.615

7.  Adolescent attachment to parents and peers in singletons and twins born with assisted and natural conception.

Authors:  M S Flykt; M Prince; M Vänskä; J Lindblom; J Minkkinen; A Tiitinen; P Poikkeus; Z Biringen; R-L Punamäki
Journal:  Hum Reprod Open       Date:  2022-03-08

8.  Tailored, psychological intervention for anxiety and/or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): statistical analysis plan for a randomised controlled trial.

Authors:  Claire L Chan; Melanie Smuk; Ratna Sohanpal; Hilary Pinnock; Stephanie J C Taylor
Journal:  Trials       Date:  2020-10-15       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.